Carcinoma of Unknown Primary — Trials

Carcinoma of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,232 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,156
Recruiting: 2,259
Ph III recruiting: 269
Growth YoY: +12.3%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,893)

clinicaltrialsPublishedShowing 401–420 of 420 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05926726	GPC3-directed CAR-T in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma	recruiting	N/A	12	RenJi HospitalOTHER	1	Jul 3, 2023	clinicaltrials
NCT05203120	A National Phase II Study of Proton Therapy in Hepatocellular Carcinoma	recruiting	N/A	50	University of AarhusOTHER	1	May 11, 2023	clinicaltrials
NCT05854823